covid 19 News and Research

RSS

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national clinical trial led by Vanderbilt University Medical Center and published in the journal CHEST.

5 Jul 2022

Immune response triggered by COVID-19 damages the brain's blood vessels to cause neurological complications

A study from the National Institutes of Health describes the immune response triggered by COVID-19 infection that damages the brain's blood vessels and may lead to short- and long-term neurological symptoms.

5 Jul 2022

Rapid expansion of telehealth consultations may increase disparities in healthcare access

Researchers at Staffordshire University warn that the rapid expansion of telehealth consultations may increase disparities in access for vulnerable people.

5 Jul 2022

COVID-19 was third leading cause of death in the United States between March 2020 and October 2021

COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute, part of the National Institutes of Health. The study appears July 5 in JAMA Internal Medicine.

5 Jul 2022

SARS-Cov-2 Omicron variant raises significant concerns about high transmissibility in China

Omicron (B.1.1.529), the fifth variant of concern (VOC) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was firstly identified in November 2021 in South Africa. Omicron contains far more genome mutations than any other VOCs ever found, raising significant concerns about its increased transmissibility and immune evasion.

5 Jul 2022

Next-generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection

In a new study,researchers suggested the inclusion of nucleocapsid protein in vaccines against SARS-CoV-2.

5 Jul 2022

Politicians have a considerable survival benefit over general populations, finds study

New data show politicians have a considerable survival advantage over general populations, based on information from 11 countries and over 57,500 politicians.

5 Jul 2022

Acute scrotal infections among COVID-19 patients significantly associated with disease severity in new study

In a new study, researchers assessed the influence of severe coronavirus disease 2019 on scrotal infections.

5 Jul 2022

Researchers explore long-term pulmonary sequelae of SARS-CoV-2 infection in the pediatric population

Researchers described the long-term pulmonary sequelae of COVID-19 in the pediatric population.

5 Jul 2022

Deep RNA sequencing with molecular dynamic simulations can detect neutralizing antibodies elicited by COVID-19 patients

In a new study, researchers reported on the non-ACE2 blocking neutralizing antibodies elicited in response to severe coronavirus disease 2019 using deep ribonucleic acid sequencing with >100 million reads per sample and molecular dynamic simulations.

5 Jul 2022

Yearly BMI changes of children found to be higher during the COVID-19 pandemic

Researchers assessed the body-mass index (BMI) variations during the COVID-19 pandemic.

5 Jul 2022

The dynamics of Delta and Omicron establishment and dominance in US states

Researchers analyzed the SARS-CoV-2 Delta and the Omicron VOCs establishment and predominance dynamics in the US.

5 Jul 2022

Crowdsourced data on overdoses pinpoints where to help

Men lined up outside the Corner of Hope, a homeless resource center, eyeing free supplies on plastic shelves inside a white van.

5 Jul 2022

Effectiveness of two and three doses of BNT162b2 against hospital and ED admissions for BA.1 and BA.2 infection

Researchers compared the effectiveness of two and three-dose regimens of COVID-19 vaccine BNT1262b against Omicron BA.1 and BA.2-related hospital and ED admissions.

5 Jul 2022

BICO; Combining Life Sciences Solutions to Further Human Health

As part of our SLAS Europe 2022 coverage, we speak to Héctor Martínez, CTO of BICO, about the technology and services they offer within life sciences research.

From Society for Laboratory Automation and Screening (SLAS) 5 Jul 2022

How Pfizer won the pandemic, reaping outsize profit and influence

The grinding two-plus years of the pandemic have yielded outsize benefits for one company — Pfizer — making it both highly influential and hugely profitable as covid-19 continues to infect tens of thousands of people and kill hundreds each day.

5 Jul 2022

Study finds hospitalizations for COVID-19–related croup increased after the onset of the Omicron variant

Researchers assessed whether croup infections among young children in the United States were associated with the emergence of new SARS-CoV-2 variants of concern Omicron.

5 Jul 2022

The evolution of COVID-19 epidemiology in Italy over the first two years of the pandemic

A recent study assessed the SARS-CoV-2 lethality and severity during the two years of the SARS-CoV-2 pandemic in Italy.

5 Jul 2022

The influence of immunosuppressive therapy on the development of adaptive immunity after SARS-CoV-2 vaccination

Researchers evaluated the impact of immunosuppressive therapies on the induction of adaptive immunity after COVID-19 vaccination.

5 Jul 2022

The varying patterns of acute respiratory infection hospitalizations before and during two pandemic years

Investigators analyzed the varying pattern of respiratory viruses resulting in hospitalizations from 2012-2013 to 2021-2022 in Canada.

5 Jul 2022

covid 19 News and Research

Trial: Convalescent plasma does not improve survival or recovery in hospitalized COVID-19 patients

Immune response triggered by COVID-19 damages the brain's blood vessels to cause neurological complications

Rapid expansion of telehealth consultations may increase disparities in healthcare access

COVID-19 was third leading cause of death in the United States between March 2020 and October 2021

SARS-Cov-2 Omicron variant raises significant concerns about high transmissibility in China

Next-generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection

Politicians have a considerable survival benefit over general populations, finds study

Acute scrotal infections among COVID-19 patients significantly associated with disease severity in new study

Researchers explore long-term pulmonary sequelae of SARS-CoV-2 infection in the pediatric population

Deep RNA sequencing with molecular dynamic simulations can detect neutralizing antibodies elicited by COVID-19 patients

Yearly BMI changes of children found to be higher during the COVID-19 pandemic

The dynamics of Delta and Omicron establishment and dominance in US states

Crowdsourced data on overdoses pinpoints where to help

Effectiveness of two and three doses of BNT162b2 against hospital and ED admissions for BA.1 and BA.2 infection

BICO; Combining Life Sciences Solutions to Further Human Health

How Pfizer won the pandemic, reaping outsize profit and influence

Study finds hospitalizations for COVID-19–related croup increased after the onset of the Omicron variant

The evolution of COVID-19 epidemiology in Italy over the first two years of the pandemic

The influence of immunosuppressive therapy on the development of adaptive immunity after SARS-CoV-2 vaccination

The varying patterns of acute respiratory infection hospitalizations before and during two pandemic years

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News